Article Information
History
- June 12, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Emily Garnett, PhD1,2,
- Joanna Jung, PhD1,2,
- Estella Tam2,
- Deepthi Rajapakshe, MS2,
- Stephen Cheney, MD1,
- Cameron Brown, PhD1,
- Kenneth L. Muldrew, MD, MPH1,
- Jing Cao, PhD1,2,
- Ila Singh, MD, PhD1,2,
- James Versalovic, MD, PhD1,2 and
- Sridevi Devaraj, PhD1,2,*
- 1Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX 77030
- 2Section of Clinical Chemistry, Division of Laboratory Medicine, Department of Pathology, Texas Children’s Hospital, Houston, TX 77030
- ↵*Corresponding Author: Sridevi Devaraj, Ph.D., DABCC, FRSC, Professor of Pathology and Immunology, Baylor College of Medicine, Director, Clinical Chemistry, Texas Children’s Hospital, 6621 Fannin St. Houston, TX 77030, sxdevara{at}texaschildrens.org, 832-826-1717
Posted June 12, 2020.
Clinical validation and performance evaluation of the automated Vitros Total Anti-SARS-CoV-2 Antibodies assay for screening of serostatus in COVID-19
